Union Health Minister Mansukh Mandaviya on Tuesday said that the Central Drug Authority CDSCO has approved the Serum Institute of India's COVID-19 vaccine Covovax, Biological E's jab Corbevax and anti-Covid pill Molnupiravir for emergencies.
Poonawalla Fincorp stated that the transaction would result in a pre-tax profit of Rs 351.85 crore. Additionally, increase its capital adequacy ratio from the existing 52.2 per cent to 56.1 per cent.
The company’s CEO Adar Poonawalla said the company would be able to export 20 to 30 million Covid-19 vaccine doses in November this year.
The political rivals rub shoulders with world ‘Leaders’: Joe Biden, Kamala Harris, Donald Trump, Abdul Ghani Baradar. Adar Poonawal figures on the list of ‘Pioneers’.
The efficacy of this approach has not been proven in field trials involving thousands of participants, Cyrus Poonawalla said
This year’s admission of Indian students to UK Universities, marks an overall increase of 19 percent in comparison to the previous year.
Santosh K More has raised the issue in a tweet tagging PM Modi and Serum Institute CEO Adar Poonawalla
While Covishield has an emergency use listing from the WHO, it is yet to receive a similar approval from the European Union.
Serum Institute of India’s Covishield has not received the EU Covid-19 Vaccination Passport due to which those vaccinated with Covishield will not be able to travel across the EU
The travellers vaccinated with Covishield may not be eligible for the European Union ‘Green Pass’- an immunity document that is meant to ease travel
Taking to Twitter, SII CEO said, 'Excited to witness the first batch of Covovax (developed by @Novavax) being manufactured this week at our facility in Pune.'
In a letter to the Union Health Ministry on May 22, Serum Institute clarified that the statement by its executive director Suresh Jadav at a recent event is not the view of the company.
Serum continues to scale up manufacturing and prioritise India. It also hopes to start delivering (vaccines) to COVAX and other countries by end of this year, Serum Institute of India said
As per BSE block deal data, Poonawalla sold 31,57,034 scrips he held in the firm at a price of Rs 373.85 per share, taking the total deal value to Rs 118.02 crore.
'We’ve not received the vaccines yet, we are in constant touch with the company. We are hopeful that vaccines will reach by tomorrow or the day after,' Delhi Chief Minister Arvind Kejriwal said
Making the announcement, Union government officials said the aim of the move was to protect the Pune-based businessman from 'potential threats'
Serum Institute of India (SII) in a statement clarified that there was an 'inaccurate comparison' done between the global prices of the vaccine with India.
This comes ahead of the new round of vaccinations from May 1 that will include all above 18.
A farmer sits near his red chillies at a deserted APMC market, during the weekend curfew imposed by the Karnataka government to curb the spread of COVID-19, in Hubballi.PTI Photo
Delhi Chief Minister & AAP National Convenor Arvind Kejriwal being welcomed by women supporters during his door-to-door campaign ahead of the Goa Assembly elections, in Goa.PTI Photo
A health worker collects swab sample of a woman for COVID-19 test, amid concerns over rising Omicron cases, in Gurugram.PTI Photo
Traffic jam on a road at Shalimar Bagh during the weekend curfew imposed by the Delhi government to curb the spread of Covid-19, in New Delhi.PTI Photo/ Shahbaz Khan
The Lajpat Nagar market wears a deserted look during the weekend curfew imposed by the Delhi government to curb the spread of Covid-19, in New Delhi.PTI Photo/ Shahbaz Khan
He would take his colour, brushes and canvas outside to paint and talk with his love. He would stand close to the window and paint, keeping an eye on his muse.
They say the violin mimics the human sound. In his case, it was that of love, of longing. He didn’t know any other way of loving.
Younger people do not have much progressive beliefs; a 2017 survey found that one-third of young people opposed inter-caste marriage.
The pandemic has made it clear that virtual learning is here to stay. In the West, the big question is whether it will dilute the quality of the college experience and education. In India, which grapples with digital divide, the question remains whether this will reach most people at all.
Even after two years of the Covid-19 pandemic, many 'informed' individuals in India continue to deny the virus with unscientific claims and unfounded data. The latest? Omicron will end the pandemic.
Across Asia there are deeply entrenched obstacles to a mode of higher education that is liberal in multiple senses – disciplinary and epistemological but also social and political.
The two incidents in the recent past, one in Mon district of Nagaland and the other at Lakhimpur Kheri in Uttar Pradesh, undermined the core principles democracy and federalism.